# Clinical Study of Caffeine for Apnea of Prematurity

> **NCT01408173** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 24 (actual)

## Conditions studied

- Apnea of Prematurity

## Interventions

- **DRUG:** NPC-11 for intravenous or oral administration.

## Key facts

- **NCT ID:** NCT01408173
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408173, "Clinical Study of Caffeine for Apnea of Prematurity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01408173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*